Neoadjuvant Histotype-Tailored Treatment with Trabectedin Not Inferior to Standard Chemotherapy with Anthracycline Plus Ifosfamide in High-Grade Myxoid Liposarcoma
Results of the expanded cohort of a randomised study from Italian, Spanish, French, and Polish sarcoma groups